Medtronic PLC (N:MDT)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 20 On Hatch, Lower Hatch Street
Tel: 1-763-5052692
IR: See website
Key People
Omar Syed Ishrak
Chairman of the Board, Chief Executive Officer
Bradley E. Lerman
Senior Vice President, General Counsel, Corporate secretary
Karen L. Parkhill
Chief Financial Officer, Executive Vice President
Carol A. Surface
Chief Human Resource Officer, Senior Vice President
Michael J. Coyle
Executive Vice President, Group President - Cardiac and Vascular Group
Hooman C. Hakami
Executive Vice President and Group President of the Diabetes Group
Robert ten Hoedt
Executive Vice President and President - EMEAC
Geoffrey S. Martha
Executive Vice President and President - Restorative Therapies Group
Robert S. White
Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group
Richard E. Kuntz
Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Business Overview
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.
Financial Overview
For the six months ended 26 October 2018, Medtronic PLC revenues increased 3% to $14.87B. Net income before extraordinary items decreased 28% to $2.18B. Revenues reflect Restrrative Therapies Group segment increase of 7% to $3.94B, Cardiovascular Group segment increase of 5% to $5.67B, United States segment increase of 3% to $7.91B. Net income was offset by Gain on sale of businesses decrease from $697M (income) to $0K, Other expense (income).
Employees: 86,000 as of Apr 27, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $132,131M as of Oct 26, 2018
Annual revenue (TTM): $30,378M as of Oct 26, 2018
EBITDA (TTM): $9,164M as of Oct 26, 2018
Net annual income (TTM): $4,704M as of Oct 26, 2018
Free cash flow (TTM): $2,266M as of Oct 26, 2018
Net Debt Last Fiscal Year: $14,883M as of Oct 26, 2018
Shares outstanding: 1,343,045,417 as of Nov 27, 2018
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization